Skip to content
Study details
Enrolling now

Impact of Behavior Modification Interventions and Lung Cancer Screening on Smoking Cessation in People Living With HIV: A Feasibility Study

AIDS Malignancy Consortium
NCT IDNCT04949464ClinicalTrials.gov data as of Apr 2026
Target enrollment

100

Study length

about 3.8 years

Ages

45–80

Locations

11 sites in CA, DC, FL +6

What this study is about

Researchers are testing if a smartphone-based smoking cessation intervention, used at the time of lung cancer screening, can help people living with HIV quit smoking. The trial will last for 1375 days and aims to enroll approximately 100 participants.

Simplified from trial records by PatientMatch.

What you may be asked to do

  • 1.Participate in Smoking Cessation Intervention
  • 2.Undergo Computed Tomography

Participation Burden

What's physically and logistically required of participants.

Logistics & Travel
In-person visits

Requires travel to a study site

Physical Intervention
Standard

How treatment is administered

Treatment Assignment
All receive treatment

Everyone gets the investigational treatment.

Extracted study details

Pulled from the trial record to show what is being tested and what the study is measuring.

Endpoints

Primary: Number of participants who complete the low dose chest CT scan within 60 days of enrollment

Secondary: Number of participants reporting anxiety related symptoms (concentration problems, memory problems, insomnia and anxiety) on the NCI PROCTCAE

Procedures

imaging

Body systems

Oncology, Immune, Infectious